CONDITION

Discoid Lupus Erythematosus

Discoid lupus erythematosus is a condition in which the immune system mistakenly targets the skin, particularly in areas exposed to sunlight. It most commonly affects the nose and face, causing changes in colour, texture, and the integrity of the skin surface. The condition tends to develop gradually, and many owners first notice crusting, loss of pigment, or a change in the normal smooth appearance of the nose. The visible signs can range from subtle loss of the usual dark colour and texture to more pronounced crusting, scaling, or ulceration. In dogs, the nose is the most frequently affected area, though the condition can occasionally involve the lips, ears, or skin around the eyes. Cats may also develop discoid lupus, though it is seen less often. This page explores the patterns that may appear, what is understood about the immune process underneath, how the condition is typically investigated, and the range of approaches used to manage it over time.

Why this matters now

Discoid lupus erythematosus tends to appear in young to middle-aged dogs, often between two and six years of age, though it can develop outside this window. Certain breeds, including Collies, Shetland Sheepdogs, German Shepherds, and Siberian Huskies, appear more frequently affected, suggesting a genetic contribution. The condition often becomes more apparent during periods of increased sun exposure, such as late spring and summer, and may be milder or less noticeable during winter months in some individuals.

The visible changes typically develop gradually over weeks to months, beginning with subtle alterations in nose colour or texture that may initially be mistaken for minor irritation. In many cases, the signs progress slowly, with periods where the appearance remains stable interspersed with phases of worsening, particularly during sunnier seasons. Some dogs experience relatively mild, persistent changes, whilst others develop more pronounced crusting, ulceration, or loss of the normal nose structure over time. The pattern and pace of change vary considerably between individuals.

Signals & patterns

Early signals

Loss of normal nose pigment

The black or dark pigment of the nose may fade to grey, pink, or mottled tones, often beginning at the edges or top surface. This depigmentation can be patchy and may seem to come and go with seasonal changes.

Roughening of nose texture

The smooth, slightly moist surface of the nose may become dry, rough, or slightly thickened. The normal 'cobblestone' pattern may flatten or lose definition, giving the nose a different feel when touched.

Fine crusting or scaling

Small crusts, flakes, or scaly patches may appear on the nose surface, sometimes resembling dried skin or minor chapping. These can be more noticeable after outdoor activity or in bright weather.

Mild redness at nose margins

The junction between the nose and the surrounding furred skin may appear slightly pink or inflamed. This redness is often subtle at first and may be easier to see in good lighting.

Later signals

Erosions or raw patches

Areas where the surface layer of the nose has been lost, leaving raw, moist, or bleeding spots. These may develop where crusts have repeatedly formed and lifted away, and can be uncomfortable or sensitive to touch.

Thickened crusts or plaques

Heavier, adherent crusts or raised, plaque-like areas may form on the nose, sometimes with a greyish or yellowish colour. These can crack or bleed if disturbed and may extend beyond the original affected area.

Extension to surrounding areas

The changes may spread from the nose to the lips, the bridge of the muzzle, or the skin around the eyes or ears. This extension tends to occur gradually and follows a similar pattern of pigment loss, crusting, or erosion.

Click to read about the biological mechanisms

How this is usually investigated

Investigation of suspected discoid lupus erythematosus typically begins with careful examination of the affected skin, noting the pattern, distribution, and character of the changes. Because several other conditions can produce similar appearances—including other immune-mediated skin diseases, fungal infections, and tumours—biopsy of the affected tissue is often needed to clarify the diagnosis. Blood tests may be considered to assess whether signs of more widespread immune activity are present, particularly if there is concern that changes extend beyond the skin.

Physical examination

Purpose: Examination allows assessment of the extent and character of skin changes, including depigmentation, crusting, ulceration, and loss of normal texture. The pattern of involvement—particularly whether the nose, lips, ears, or eye margins are affected—can help narrow the range of possible causes.
Considerations: The appearance alone cannot distinguish discoid lupus from other immune-mediated or infectious skin diseases. Many conditions produce overlapping clinical signs, so further testing is usually needed for confirmation.

Skin biopsy and histopathology

Purpose: Biopsy involves removing a small sample of affected skin, which is then examined under the microscope. The presence of immune cell infiltration at the junction between skin layers, along with damage to the basement membrane zone and loss of pigment cells, can support the diagnosis of discoid lupus.
Considerations: Biopsy requires local or general anaesthesia and leaves a small wound that typically heals within one to two weeks. The histological changes can sometimes overlap with other immune-mediated skin conditions, and interpretation may depend on the experience of the pathologist and the quality of the sample.

Antinuclear antibody (ANA) testing

Purpose: This blood test detects antibodies that target components of cell nuclei, which can be present in some immune-mediated diseases. In discoid lupus, ANA results are often negative, which can help distinguish the condition from systemic lupus erythematosus, where positive results are more common.
Considerations: A negative ANA test does not rule out discoid lupus, and a positive result does not confirm it. The test is more useful for assessing whether there may be broader immune activity beyond the skin.

Bacterial or fungal culture

Purpose: If secondary infection is suspected, culture of skin surface material or tissue samples can identify bacteria or fungi that may be contributing to crusting, ulceration, or delayed healing. Secondary infection is relatively common in skin compromised by immune activity.
Considerations: Culture results take several days and may not always reflect the underlying cause of the skin changes. Treatment of secondary infection can improve appearance and comfort, but does not address the immune-mediated process itself.

Exclusion of other conditions

Purpose: Other causes of nasal and facial skin changes—such as pemphigus foliaceus, mucocutaneous pyoderma, dermatophytosis, and epitheliotropic lymphoma—may be considered and investigated depending on the clinical picture. This may involve additional biopsies, impression smears, or specific antibody tests.
Considerations: The process of exclusion can involve multiple tests over time, particularly if the initial biopsy results are ambiguous or if the response to treatment is incomplete. Some conditions can only be confidently distinguished after observing how the skin responds to specific therapies.

Options & trade-offs

Management of discoid lupus erythematosus is usually tailored to the individual, taking into account the extent and severity of skin changes, the practicality of different interventions, and how the condition responds over time. Most approaches aim to reduce immune activity in the skin, limit further damage from ultraviolet light, and manage secondary complications such as infection. What works well for one animal may be less effective or less practical for another, and combinations of approaches are common.

Topical corticosteroids or immunomodulators

Creams or ointments containing corticosteroids such as betamethasone or hydrocortisone, or non-steroidal immunomodulators like tacrolimus, can be applied to affected areas to reduce local inflammation. These are often used once or twice daily, with the frequency adjusted depending on response. Topical treatment allows delivery of medication directly to the skin whilst minimising systemic exposure.

Trade-offs: Application to the nose can be challenging, as many dogs lick the area soon after treatment. Some owners find it difficult to apply medication consistently, particularly in dogs that are sensitive around the face. Skin thinning or delayed healing can occur with prolonged use of potent corticosteroids, and not all individuals respond adequately to topical therapy alone.

Oral immunosuppressive medication

Medications such as prednisolone, azathioprine, or ciclosporin can be given by mouth to reduce systemic immune activity. These are often started at higher doses and then tapered to the lowest effective level over weeks to months. Oral treatment may be considered when topical therapy is impractical or when skin changes are extensive or progressive.

Trade-offs: Systemic immunosuppression carries the risk of side effects, including increased thirst and urination, weight gain, gastrointestinal upset, or increased susceptibility to infection. Some medications require regular blood monitoring to assess liver or bone marrow function. Long-term use may necessitate ongoing medication and periodic reassessment, which can be a consideration for some owners.

Sun avoidance and physical protection

Reducing exposure to ultraviolet light—by limiting time outdoors during peak sunlight hours, seeking shade, or using physical barriers such as sun-protective balms or clothing—can help reduce flare-ups in some individuals. Some owners find that applying pet-safe sunscreens to the nose and face provides additional protection, though acceptance varies between animals.

Trade-offs: Practical sun avoidance can be difficult in active dogs or those with outdoor lifestyles. Physical barriers such as balms may be licked off, and not all animals tolerate clothing or other protective measures. Sun protection is often most useful as part of a broader management strategy rather than as a sole intervention.

Vitamin E and omega-3 fatty acid supplementation

Oral supplementation with vitamin E or omega-3 fatty acids derived from fish oil is sometimes used alongside other treatments, based on their antioxidant and anti-inflammatory properties. Doses vary, and response, when it occurs, tends to develop over several weeks. These supplements are generally well tolerated and may support skin health more broadly.

Trade-offs: Evidence for efficacy in discoid lupus is largely anecdotal, and many animals show little change with supplementation alone. High doses of vitamin E can occasionally interfere with clotting, particularly in animals on other medications. Supplements are often used as adjuncts rather than primary treatments.

Management of secondary infection

Bacterial or fungal infections can develop in skin damaged by immune activity, leading to increased crusting, discharge, or delayed healing. Topical or oral antimicrobials may be used for a defined period to clear secondary infection, which can improve comfort and appearance. The choice of antimicrobial may be guided by culture results.

Trade-offs: Treating secondary infection does not address the underlying immune process, and recurrence is common if the immune activity is not also managed. Prolonged or repeated antimicrobial use can contribute to resistance, so treatment is usually reserved for periods when infection is clinically apparent.

Common misconceptions

Misconception:

"Discoid lupus erythematosus will always progress to systemic lupus, affecting internal organs."

Reality:

Discoid lupus erythematosus is a skin-limited form of lupus, and progression to systemic lupus erythematosus is rare. The two conditions are distinct, though they share some immune mechanisms. Most dogs with discoid lupus do not develop signs of systemic disease, such as joint inflammation, kidney involvement, or widespread immune-mediated blood cell destruction.

Misconception:

"Once the nose returns to a normal appearance, treatment can be stopped permanently."

Reality:

Discoid lupus erythematosus is typically a chronic condition, and many individuals require ongoing management to maintain improvement. Withdrawal of treatment often leads to recurrence of signs, particularly during periods of increased sun exposure. The goal is usually long-term control rather than cure, and some animals need continued low-level therapy for months to years.

Misconception:

"The condition is contagious and can spread to other pets or people."

Reality:

Discoid lupus erythematosus is an immune-mediated condition, not an infection, and cannot be transmitted between animals or to humans. The changes seen in the skin result from the individual's own immune system targeting skin structures, not from an external pathogen. Other pets in the household are not at risk from proximity to an affected animal.

Related conditions

Pemphigus

Pemphigus foliaceus is another autoimmune skin condition in which the immune system attacks components of the skin, though in pemphigus the target is the connections between skin cells rather than the dermal–epidermal junction. Both conditions can produce crusting and scaling, particularly on the face, and may be considered alongside one another when investigating autoimmune skin disease.

Sebaceous Adenitis

Sebaceous adenitis involves immune-mediated inflammation directed at the sebaceous glands, and in some cases can produce scaling and crusting that may resemble discoid lupus, particularly around the head. Both conditions reflect an immune process targeting skin structures, though the pattern of tissue involvement and distribution tends to differ.

Feline Calicivirus

Feline calicivirus can cause ulceration and crusting around the nose and mouth in cats, and may occasionally be considered in the differential diagnosis when a cat presents with nasal lesions. Discoid lupus in cats is less common than in dogs, and infectious causes such as calicivirus are often explored first.

Squamous Cell Carcinoma

Squamous cell carcinoma in cats often affects sun-exposed, lightly pigmented areas such as the nose and ears, and the early changes—loss of pigment, crusting, or texture change—can sometimes resemble the presentation of discoid lupus. Both conditions may be influenced by ultraviolet exposure, though the underlying process and progression differ.

Histiocytoma

Pyoderma describes bacterial infection of the skin, and in some cases secondary bacterial colonisation can complicate discoid lupus when the skin barrier is disrupted by crusting or ulceration. Distinguishing primary autoimmune change from secondary infection may require careful assessment and sometimes culture.

For those observing ongoing changes in nose colour, texture, or comfort, or noticing patterns that vary with season or sun exposure, conversations about the range of management options and their practical fit can be useful. Understanding how other immune-mediated skin conditions differ in their course and treatment, or exploring the broader context of immune health, may provide additional perspective. Some owners find it helpful to track the appearance of affected areas over time, noting any relationship to environmental factors or changes in routine.

Last reviewed: 1 July 2026 · Dr Alastair Greenway MRCVS